Manifestations possibles : douleur locale au point de perfusion, ecchymose post-retrait cathter, cphales transitoires (dshydratation), nauses lgres (perfusion trop rapide), got mtallique (vitamines B)
What is more, no clear trend for a change in pharmacokinetics was evident across groups with increasing renal dysfunction 12 that allowed us to administer the same dose of the drug and the same blood sampling time points in patients with different degree of renal impairment who were included in our study
The value of any emerging option lies in what it adds to a complete approach, not in any illusion that it could replace the deeper, multifaceted work that genuine recovery requires
In recent years, the prognosis of HF has improved slightly thanks to newer and more effective therapies, but mortality remains high, if not higher, compared with previous years